Diffuse infiltration and low density on NECT
Multiple well-defined, homogeneous, low-density (CECT) or high-intensity (T2WI) masses
•
Liver metastases
Hypovascular metastases: Low-density center with peripheral rim or target-like enhancement
Hypervascular metastases: Hyperdense (intense) on arterial phase CECT or CEMR
•
Cystic metastases (< 20 HU)
Fluid levels, debris, mural nodules
•
Liver-specific MR contrast agents (e.g., gadoxetate)
Metastases: Hypointense lesions made more apparent compared with bright enhancement of liver on delayed phase imaging
•
CECT is usually best as “whole body” screening test
Even better if combined as PET/CT
Metastases and lymphoma are usually FDG-avid masses within liver
•
Decision for thermal ablation or surgical resection
May require most sensitive tests (gadoxetate-enhanced MR, PET/CT, or intraoperative US)
TOP DIFFERENTIAL DIAGNOSES
•
Multifocal fatty infiltration (steatosis)
•
Multifocal hepatocellular carcinoma or cholangiocarcinoma
DIAGNOSTIC CHECKLIST
•
In absence of a known primary tumor or other metastases:
Hepatic lesions that are “too small to characterize” rarely represent metastases
Lesions that are lower than blood density on NECT rarely represent metastases
TERMINOLOGY
Abbreviations
Definitions
•
Lymphoma: Neoplasm of lymphoid tissues
•
Metastases: Malignant spread of neoplasm to hepatic parenchyma
IMAGING
General Features
•
Best diagnostic clue
Lymphoma: Lobulated, low-density, hypovascular masses
Metastases: Multiple heterogeneous, spherical lesions scattered throughout liver
•
Location
Lymphoma (HD and NHL) favors periportal areas due to high content of lymphatic tissue
•
Size
Variable; few millimeters to > 10 centimeters
•
Morphology
Usually spherical
•
Key concepts
Hepatic lymphoma
–
Secondary (more common): Seen in > 50% of patients with Hodgkin disease (HD) or non-Hodgkin lymphoma (NHL)
–
High-risk groups: Transplant recipients and AIDS patients
–
Types of hepatic lymphoma: NHL > Hodgkin
Liver metastases
–
Most common malignant tumor of liver
Compared to primary malignant tumors (18:1)
–
Liver is 2nd only to regional lymph nodes as site of metastatic disease
–
Autopsy studies reveal 55% of oncology patients have liver metastases
CT Findings
•
NECT
Lymphoma
–
Diffuse infiltration: Indistinguishable from normal liver or steatosis
Metastases
–
Isodense, hypodense, or hyperdense (melanin or calcification)
•
CECT
Lymphoma
–
Diffuse infiltration and low density
–
Multiple well-defined, homogeneous, low-density masses
Hypovascular metastases
–
Low-attenuation center with peripheral rim enhancement (e.g., epithelial metastases)
–
Indicates vascularized viable tumor in periphery and hypovascular or necrotic center
–
Rim enhancement may also be due to compressed normal parenchyma
Hypervascular metastases
–
Hyperdense in late arterial phase images
–
May have internal necrosis without uniform hyperdense enhancement
–
Hypo-/isodense on NECT and portal venous phase
Often washout to become hypodense on delayed phase CECT
–
Examples: endocrine (islet cell), carcinoid, thyroid and renal carcinomas, and pheochromocytoma
Cystic metastases (< 20 HU)
–
Fluid levels, debris, mural nodules
MR Findings
•
T1WI
Lymphoma and metastases: Hypointense lesions
–
Melanoma metastases: Hyperintense due to melanin
•
T2WI
Lymphoma: Focal or diffusely hyperintense
Metastases
–
Moderate to high signal
–
Light bulb sign: Very high signal intensity (e.g., cystic and neuroendocrine metastases)
Mimic cysts or hemangiomas but usually with thick wall or fluid level
•
T1WI C+
Hypovascular metastases
–
Same pattern of enhancement as CECT
–
Low signal in center and peripheral rim enhancement
–
Perilesional enhancement may be tumor vascularity or hepatic edema
Hypervascular metastases
–
Hyperintense enhancement on arterial phase
•
Hepatobiliary contrast agents (e.g., gadoxetate [Eovist, Primovist])
On delayed scans, normal liver is brightly enhanced
Metastases are conspicuous as hypointense focal lesions
Most sensitive, but not specific, imaging test for determining presence and number of metastases
Ultrasonographic Findings
•
Grayscale ultrasound
Hepatic lymphoma
–
Multiple well-defined, hypoechoic lesions
–
Diffuse form: May detect innumerable subcentimeter hypoechoic foci
Otherwise indistinguishable from normal or fatty liver
Hypoechoic metastases
–
Usually from hypovascular tumors
Hyperechoic metastases
Get Clinical Tree app for offline access